There is considerable evidence to suggest that Sox2 is critical for maintaining ovarian cancer stem cell pluripotency as well as determining stem cell fate, and targeting Sox2 may be therapeutically beneficial [47,48]. The gene discussed is SOX2; the disease is ovarian cancer.